These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12594562)

  • 1. Proton magnetic resonance spectroscopy ((1)H MRS) of human brain tumours: assessment of differences between tumour types and its applicability in brain tumour categorization.
    Majós C; Alonso J; Aguilera C; Serrallonga M; Pérez-Martín J; Acebes JJ; Arús C; Gili J
    Eur Radiol; 2003 Mar; 13(3):582-91. PubMed ID: 12594562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult primitive neuroectodermal tumor: proton MR spectroscopic findings with possible application for differential diagnosis.
    Majós C; Alonso J; Aguilera C; Serrallonga M; Acebes JJ; Arús C; Gili J
    Radiology; 2002 Nov; 225(2):556-66. PubMed ID: 12409595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of proton MR spectroscopy in the diagnosis of radiologically atypical intracranial meningiomas.
    Majós C; Alonso J; Aguilera C; Serrallonga M; Coll S; Acebes JJ; Arús C; Gili J
    Neuroradiology; 2003 Mar; 45(3):129-36. PubMed ID: 12684713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain tumor classification by proton MR spectroscopy: comparison of diagnostic accuracy at short and long TE.
    Majós C; Julià-Sapé M; Alonso J; Serrallonga M; Aguilera C; Acebes JJ; Arús C; Gili J
    AJNR Am J Neuroradiol; 2004; 25(10):1696-704. PubMed ID: 15569733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating diffuse World Health Organization grade II and IV astrocytomas with ex vivo magnetic resonance spectroscopy.
    Vettukattil R; Gulati M; Sjøbakk TE; Jakola AS; Kvernmo NA; Torp SH; Bathen TF; Gulati S; Gribbestad IS
    Neurosurgery; 2013 Feb; 72(2):186-95; discussion 195. PubMed ID: 23147779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies.
    Gill SS; Thomas DG; Van Bruggen N; Gadian DG; Peden CJ; Bell JD; Cox IJ; Menon DK; Iles RA; Bryant DJ
    J Comput Assist Tomogr; 1990; 14(4):497-504. PubMed ID: 2164536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1H- and (31)P-MR spectroscopy of primary and recurrent human brain tumors in vitro: malignancy-characteristic profiles of water soluble and lipophilic spectral components.
    Lehnhardt FG; Röhn G; Ernestus RI; Grüne M; Hoehn M
    NMR Biomed; 2001 Aug; 14(5):307-17. PubMed ID: 11477651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy.
    Ishimaru H; Morikawa M; Iwanaga S; Kaminogo M; Ochi M; Hayashi K
    Eur Radiol; 2001; 11(9):1784-91. PubMed ID: 11511902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance spectroscopy in intracranial tumours of glial origin.
    Jaskólski DJ; Fortuniak J; Majos A; Gajewicz W; Papierz W; Liberski PP; Sikorska B; Stefańczyk L
    Neurol Neurochir Pol; 2013; 47(5):438-49. PubMed ID: 24166565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy.
    Kinoshita Y; Yokota A
    NMR Biomed; 1997 Jan; 10(1):2-12. PubMed ID: 9251109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of magnetic resonance spectroscopy and echoplanar perfusion-weighted MRI in the initial assessment of brain tumours.
    Fayed N; Modrego PJ
    J Neurooncol; 2005 May; 72(3):261-5. PubMed ID: 15937650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of proton MRS in the differential diagnosis of brain tumors and tumor-like processes.
    Gajewicz W; Papierz W; Szymczak W; Goraj B
    Med Sci Monit; 2003 Sep; 9(9):MT97-105. PubMed ID: 12960934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton magnetic resonance spectroscopy of brain tumors: an in vitro study.
    Kinoshita Y; Kajiwara H; Yokota A; Koga Y
    Neurosurgery; 1994 Oct; 35(4):606-13; discussion 613-4. PubMed ID: 7808603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation between pilocytic astrocytoma and glioblastoma: a decision tree model using contrast-enhanced magnetic resonance imaging-derived quantitative radiomic features.
    Dong F; Li Q; Xu D; Xiu W; Zeng Q; Zhu X; Xu F; Jiang B; Zhang M
    Eur Radiol; 2019 Aug; 29(8):3968-3975. PubMed ID: 30421019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive grading of astrocytic tumours from the relative contents of myo-inositol and glycine measured by in vivo MRS.
    Candiota AP; Majós C; Julià-Sapé M; Cabañas M; Acebes JJ; Moreno-Torres A; Griffiths JR; Arús C
    JBR-BTR; 2011; 94(6):319-29. PubMed ID: 22338386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of myo-inositol levels and grading of cerebral astrocytomas.
    Castillo M; Smith JK; Kwock L
    AJNR Am J Neuroradiol; 2000 Oct; 21(9):1645-9. PubMed ID: 11039343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors.
    Tien RD; Lai PH; Smith JS; Lazeyras F
    AJR Am J Roentgenol; 1996 Jul; 167(1):201-9. PubMed ID: 8659372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro study of astrocytic tumour metabolism by proton magnetic resonance spectroscopy.
    Likavcanová K; Dobrota D; Liptaj T; Prónayová N; Mlynárik V; Belan V; Galanda M; Béres A; De Riggo J
    Gen Physiol Biophys; 2005 Sep; 24(3):327-35. PubMed ID: 16308427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linear discriminant analysis of brain tumour (1)H MR spectra: a comparison of classification using whole spectra versus metabolite quantification.
    Opstad KS; Ladroue C; Bell BA; Griffiths JR; Howe FA
    NMR Biomed; 2007 Dec; 20(8):763-70. PubMed ID: 17326043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.